Small Cap Spinal and Back Pain Stocks to Treat Your Portfolio: ATEC, OFIX, GMED & BRTX

Published: Wednesday, June 19, 2013 7:15 AM PDT

Small cap stocks Alphatec Holdings Inc (ATEC), Orthofix International NV (OFIX), Globus Medical Inc (GMED) and BioRestorative Therapies (BRTX) are focused on treating back pain or spinal disorders.

Rating N/A

Do Investors Have Unholy Returns in These Christian Stocks? TSN, ALK, ZN & AVEMX

Published: Wednesday, June 19, 2013 2:51 AM PDT

Tyson Foods, Inc. (TSN), Alaska Air Group, Inc. (ALK), Zion Oil & Gas, Inc. (ZN) and the Ave Maria Catholic Values Fund (AVEMX) are among the more pious Christian stocks or investments available for investors.

Rating N/A

The Truth About Freddie and Fannie

Published: Tuesday, June 18, 2013 4:23 PM PDT

Why the U.S. Government Loses Game, Set, and Match Against Freddie and Fannie Stockholders

Rating N/A

Cardica (CRDC) is Hangin' By a Thread

Published: Monday, June 17, 2013 12:19 PM PDT

At first glance, Cardica, Inc. (NASDAQ:CRDC) doesn't seem like it's doing anything other than moving sideways. Take a closer look though.

Rating N/A

BioRestorative Therapies (BRTX) Stirs Its Pot. Time to Take Notice.

Published: Monday, June 17, 2013 8:54 AM PDT

BioRestorative Therapies, Inc. (OTCBB:BRTX) is off and running, fully recognizing that the PR effort is half the battle.

Rating N/A

Take the Hint That Implant Sciences (IMSC) is Dropping

Published: Monday, June 17, 2013 6:55 AM PDT

Implant Sciences Corporation (OTCMKTS:IMSC) may have paused today, but that's only a temporary thing - the shape of the chart says the bulls are really testing the water.

Rating N/A

Pharma Stock Under $10 With Huge Upside Potential: Venaxis Inc (APPY)

Published: Friday, June 14, 2013 7:37 AM PDT

Venaxis approaches Q4 catalyst events. The company is expected to present FDA pivotal trial results in early fourth quarter for APPY 1 Test, a rapid, protein biomarker-based assay for identifying patients at low risk for appendicitis, and potentially submit a New Drug Application (NDA) to the FDA thereafter.

Rating N/A

Northwest Biotherapeutics: Targeting Glioblastoma with Immunotherapy

Published: Thursday, June 13, 2013 11:38 AM PDT

Since DCVax offers a radically new mechanism of action to target the tumor cells without introducing toxicity, market penetration could be very significant if the Phase III results show significant overall survival (OS) benefit. Data from Phase I/II development for DCVax-L implies that we may see median 19-20 month extension of late-stage glioblastoma patients’ lifespans – significantly better than glioblastoma therapies on the market today.

Rating N/A

Sequenom Revs Its Engine For All the Right Reasons (ILMN, GNOM, SQNM)

Published: Thursday, June 13, 2013 9:12 AM PDT

Illumina Inc. (NASDAQ:ILMN), Complete Genomics, Inc. (NASDAQ:GNOM), and Sequenom, Inc. (NASDAQ:SQNM) may all be in the same business, but one of them is a superior opportunity right now.

Rating N/A

The Most Shorted Nasdaq Stock Just Begs You to Short It

Published: Wednesday, June 12, 2013 3:58 AM PDT

Small cap Central European Media Enterprises Ltd. (CETV) just can’t seem to get anything right and is sinking faster than the European economy.

Rating N/A
First « Previous 1 2 3 4 5 6 7 8 9 10 11 Next » Last
Join the 200,000+ other Members who take full advantage of all the SmallCap Network has to offer: Sign In or Join